Amid rising global tensions and sustained U.S. defense spending, Lockheed Martin's unique role in stitching together America's missile and space defense architecture presents a compelling investment case, analysts argue.
A year after Hanoi and Washington elevated ties to a Comprehensive Strategic Partnership, an internal Vietnamese military document reveals deep-seated fears of U.S. aggression and 'color revolutions,' highlighting the complex duality at the heart of Vietnam's foreign policy.
Newly obtained emails reveal former Border Patrol operations chief Gregory Bovino resisted calls for more targeted enforcement months before agents under his command were involved in two deadly shootings in Minneapolis, exposing internal divisions within DHS.
As Archer Aviation advances toward FAA certification for its Midnight air taxi, bullish investors point to its strong liquidity and strategic partnerships. But with the company still pre-revenue and burning cash, the path to commercial launch by 2026 remains a high-stakes race against time and regulation.
United Parcel Service (UPS) shares have surged nearly 20% over the past three months, closing at $110.27 and prompting a fresh wave of analysis on whether the stock represents a value opportunity or has run ahead of itself. Divergent valuation models paint conflicting pictures for investors.
Amalgamated Financial (AMAL) shares have delivered stellar multi-year returns, but a closer look at valuation models suggests the stock may be significantly undervalued despite its strong run. We analyze the numbers behind the rally.
Shares of the boutique investment bank Perella Weinberg Partners have rallied sharply over the past month, riding a wave of renewed optimism in the advisory sector. However, its premium valuation and mixed long-term performance are prompting investors to weigh the risks against the potential rewards.
Johnson & Johnson's oncology portfolio gains momentum with new clinical data for prostate cancer drug Erleada and a broader FDA label for multiple myeloma therapy Darzalex Faspro, reinforcing its competitive stance in key cancer markets.
A federal judge has indefinitely blocked the Trump administration's plan to end Temporary Protected Status for Haitians, delivering a reprieve to hundreds of thousands of immigrants and sharply criticizing the decision as 'arbitrary' and potentially racially motivated.
India's latest budget outlines a massive strategic pivot, channeling over $10 billion into domestic rare earths processing and clean energy. The move aims to secure critical mineral supply chains and boost nuclear power, reducing reliance on foreign sources, particularly China.
A Northern California jewelry store robbery was abruptly disrupted when a civilian commandeered the suspects' idling vehicle and rammed it into the storefront, forcing the armed thieves to flee on foot, police report.
Amid a challenging environment for traditional energy, Natural Resource Partners L.P. (NRP) is generating robust free cash flow from its vast mineral rights portfolio, aggressively paying down debt, and positioning for a potential dividend resurgence. With a unique asset base including carbon sequestration rights, some analysts see a compelling value story unfolding.
Emerging from bankruptcy ashes, the 52-year-old Bed Bath & Beyond brand is executing a radical pivot, acquiring Tokens.com to build a platform for tokenized real estate and asset-backed finance—a stark departure from its big-box retail roots.
As the 2026 election cycle approaches, Gray Media emerges as a contrarian play. Analysts point to its potential for a significant re-rating, driven by political advertising cyclicality, stable retransmission fees, and a trove of undervalued hard assets.
A series of fabricated images purporting to show New York City Mayor Zohran Mamdani and his mother with Jeffrey Epstein and other prominent figures spread across social media this week, highlighting the escalating challenge of AI-driven political disinformation.
Adtalem Global Education posts strong Q2 fiscal 2026 results, raising revenue to $503.39M and net income to $76.38M, while reaffirming full-year guidance. The company's new $750M share repurchase authorization signals a dual commitment to capital returns and strategic growth in its healthcare education portfolio, even as regulatory and enrollment challenges linger.
The data analytics firm's quarterly results soared past estimates, fueled by surging government contracts. CEO Alex Karp touts 'iconic' performance while facing renewed scrutiny over the company's role in immigration enforcement.
Once an open-source developer tool, GitLab has transformed into a unified AI-powered DevSecOps platform. With strong enterprise adoption and a focus on solving the 'AI Paradox,' the company presents a compelling, if competitive, growth story for investors.
Once a niche mobile data transfer tool, Cellebrite has transformed into a critical digital intelligence platform for global law enforcement and enterprises. With a shift to a high-margin SaaS model and strategic AI investments, analysts see a compelling growth trajectory ahead.
Shares of OR Royalties (TSX:OR) have retreated nearly 15% over the past week, prompting investors to reassess the valuation of the precious metals royalty company following its multi-year bull run. With the stock still up significantly year-over-year, we examine whether the dip presents a value entry or reflects justified concerns over its premium pricing.
